The clinical diagnostic reagent Department of Jiangsu Zhongxin Pharmaceutical Co., Ltd. focuses on the frontier of modern clinical diagnostic reagents. With the application of Biochemistry, microbiology, immunology, molecular biology, cell biology, protein science and other technologies, the clinical diagnostic reagent Department of Jiangsu Zhongxin Pharmaceutical Co., Ltd. has developed professional technical services and related products for hospitals, biotechnology companies, scientific research institutions, etc.

　　The clinical diagnostic reagent Department has a team with good scientific research quality and close cooperation. In the process of scientific research, the division of labor is clear and cooperation is made to ensure the efficient and orderly implementation of the project. In the team, the members have the skilled biochemistry, microbiology, immunology, cell culture, molecular cloning, protein separation and purification technology, which provides a strong guarantee for the successful development of clinical diagnostic reagents.

　　Clinical diagnostic reagent department is committed to developing convenient, fast and accurate diagnostic kits for microbial drug sensitivity, and provide services for rational use of antibiotics; The products which can judge the healthy blood source in time are developed by using immunocolloidal gold technology; The innovative gene detection technology is used to provide information for personalized drug delivery of tumor treatment and guide the rational use of drugs in clinic.

　　The clinical diagnostic reagent Department has built a microbial laboratory, including biosafety cabinet, anaerobic incubator, vacuum drying box, etc., which ensures the smooth development of microbial diagnostic reagents; The Department has a good platform for molecular biology, cell culture, immunology technology and protein purification, which can provide guarantee for the development of immunodiagnostic reagents; In order to develop molecular diagnostic reagents, the company purchased real time PCR. Advanced experimental instruments and technical platforms provide sufficient guarantee for the development of diagnostic reagent products.

　　At present, the clinical diagnostic reagent department is focusing on the development of the following three types of diagnostic reagent products:

　　Among them, the diagnostic reagents of microbial drug sensitivity have entered the clinical experiment stage.

　　The products to be developed by clinical diagnostic reagent Department include rapid diagnosis technology of microorganism, diagnosis technology of myocardial infarction and rapid diagnosis reagent of gynecological diseases.